Are you hurt? Here’s to better wound care. Singapore-based biomaterials startup Bioactivx develops synthetic, bio-inspired skin substitutes to help treat skin wounds.

• Now, they’ve just raised a $1.43M seed!

Investor check. Cocoon Capital led the round, while global strategic investors joined in.

‍

😷 Healing burn wounds

According to the World Health Organization, around 11M people suffer from burn injuries every year, and 180K die because of it. 

• The most common way to treat burn patients is to do skin grafts, which use animal-derived collagen. 
• But…this comes with high infection risks and ethical and cultural barriers. 

‍

🌱 Where Bioactivx comes in

Bioactivx’ approach uses a synthetic regenerative platform that mimics the body’s natural healing process without relying on animal materials. 

• Their Bioactiv Matrix method means no infection risk, no need for cold chain storage, and no cultural restrictions. 
• In some cases, porcine (pork) or bovine (cattle)-derived products are restricted for cultural or religious reasons.

‍

🩸 What’s next? 

They’ll push for the commercialization of Bioactiv Matrix and also seek global regulatory approval. 

• They’ll also develop new products, Bioactiv Foam (for acute and chronic wounds) and Bioactiv Cellulose (for ulcers and long-term care).
• Oh, and they’re going to scale their Singapore facility to ISO 13485 standards.